Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bioventus Inc. - Class A Common Stock (NQ:BVS)

14.26 +0.37 (+2.66%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 506,038
Open 13.76
Bid (Size) 14.09 (100)
Ask (Size) 14.63 (100)
Prev. Close 13.89
Today's Range 13.71 - 14.39
52wk Range 6.255 - 15.89
Shares Outstanding 10
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Bioventus (BVS) Q2 2026 Earnings Call Transcript ↗
Pain Treatments surged 11.5% as management explores strategic alternatives. 
Via The Motley Fool
Topics Earnings
News headline image
Bioventus Q2 Earnings Call Highlights ↗
Bioventus (NASDAQ:BVS) reported second-quarter 2026 revenue growth of 4% and reiterated its full-year financial outlook, citing double-digit expansion in its Pain Treatments business, continued debt... 
Via MarketBeat
Topics Earnings

Performance

YTD
+97.8%
+97.8%
1 Month
+14.7%
+14.7%
3 Month
+34.1%
+34.1%
6 Month
+70.2%
+70.2%
1 Year
+93.5%
+93.5%

More News

Read More
Bioventus (NASDAQ:BVS) Falls After Q2 Revenue Miss, Launches Strategic Review ↗
Via Chartmill
News headline image
Bioventus Reports Second Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
Bioventus Inc (NASDAQ:BVS) Smashes Q1 Estimates and Lifts Guidance, Shares Rally ↗
Via Chartmill
Bioventus Inc (NASDAQ:BVS) Reports Q4 Earnings Beat and Strong 2026 Outlook ↗
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For November 4, 2025 ↗
Via Benzinga
News headline image
Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026
From Bioventus, Inc.
Via GlobeNewswire
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls ↗
Via MarketBeat
Topics Initial Public Offering
News headline image
Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus (BVS) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics World Trade
News headline image
Bioventus Reports First Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Curious about the stocks that are showing activity after the closing bell on Tuesday? ↗
Via Chartmill
News headline image
Bioventus (BVS) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings World Trade
News headline image
Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference
From Bioventus, Inc.
Via GlobeNewswire
News headline image
These stocks are gapping in today's session ↗
Via Chartmill
News headline image
Bioventus Inc (NASDAQ:BVS) Reports Q3 2025 Earnings Beat and Strong Profitability Growth ↗
Via Chartmill
Topics Earnings
News headline image
Bioventus Reports Third Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
From Bioventus, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Bioventus Inc. - Class A Common Stock publicly traded?
Yes, Bioventus Inc. - Class A Common Stock is publicly traded.
What exchange does Bioventus Inc. - Class A Common Stock trade on?
Bioventus Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bioventus Inc. - Class A Common Stock?
The ticker symbol for Bioventus Inc. - Class A Common Stock is BVS on the Nasdaq Stock Market
What is the current price of Bioventus Inc. - Class A Common Stock?
The current price of Bioventus Inc. - Class A Common Stock is 14.26
When was Bioventus Inc. - Class A Common Stock last traded?
The last trade of Bioventus Inc. - Class A Common Stock was at 08/14/26 04:00 PM ET
What is the market capitalization of Bioventus Inc. - Class A Common Stock?
The market capitalization of Bioventus Inc. - Class A Common Stock is 142.60
How many shares of Bioventus Inc. - Class A Common Stock are outstanding?
Bioventus Inc. - Class A Common Stock has 143 shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.